| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |